1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => FreeToRead
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


  
    































































































































    Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI–Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas | American Journal of Neuroradiology  
    



















    































    
  
  




    
    

  

      


    

      

  
  
  

    

  

    

  

                
    

      

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



    

  


  


  


  
  
  
  
  
  

  	      


    
      

    
  
    
        
    

  

    
                        

  

                
    

      

	  

		
		

			

			  

  
      
  
  

    

  
  
      
Research ArticleBrain

  
      

  
      
Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI–Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas
  
    	
T.B. Nguyen, G.O. Cron, J.F. Mercier, C. Foottit, C.H. Torres, S. Chakraborty, J. Woulfe, G.H. Jansen, J.M. Caudrelier, J. Sinclair, M.J. Hogan, R.E. Thornhill and I.G. Cameron

  
    	
American Journal of Neuroradiology January 2015,  36 (1) 63-69; DOI: https://doi.org/10.3174/ajnr.A4006 

  
  
  



  


  
  



			

		

	
	
 	
	  
  

		
		

			

			  

  
      
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    
References
  1. 1.↵


    1. Bernstein  M, 
    2. Berger  MS
    1. 

    2. Kalkanis  SN, 
    3. Rosenblum  ML
    . Malignant gliomas. In: Bernstein  M, Berger  MS, eds. Neuro-oncology: The Essentials. 2nd ed. New York: Thieme Medical Publishers; 2008:254–65
  2. 2.↵


    1. 

    2. Chaichana  K, 
    3. McGirt  M, 
    4. Niranjan  A, et al
    . Prognostic significance of contrast-enhancing low-grade gliomas in adults and a review of the literature. Neurol Res 2009;31:931–39
    CrossRefPubMed
  3. 3.↵


    1. 

    2. Chang  EF, 
    3. Smith  JS, 
    4. Chang  SM, et al
    . Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. J Neurosurg 2008;109:817–24
    CrossRefPubMedWeb of Science
  4. 4.↵


    1. 

    2. Pope  WB, 
    3. Sayre  J, 
    4. Perlina  A, et al
    . MR imaging correlates of survival in patients with high-grade gliomas. AJNR Am J Neuroradiol 26:2466–74
  5. 5.↵


    1. 

    2. Law  M, 
    3. Young  RJ, 
    4. Babb  JS, et al
    . Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. Radiology 2008;247:490–98
    CrossRefPubMedWeb of Science
  6. 6.↵


    1. 

    2. Hipp  SJ, 
    3. Steffen-Smith  E, 
    4. Hammoud  D, et al
    . Predicting outcome of children with diffuse intrinsic pontine gliomas using multiparametric imaging. Neuro Oncol 2011;13:904–09
    Abstract/FREE Full Text
  7. 7.↵


    1. 

    2. Hirai  T, 
    3. Murakami  R, 
    4. Nakamura  H, et al
    . Prognostic value of perfusion MR imaging of high-grade astrocytomas: long-term follow-up study. AJNR Am J Neuroradiol 2008;29:1505–10
    Abstract/FREE Full Text
  8. 8.↵


    1. 

    2. Ellingson  B, 
    3. Zaw  T, 
    4. Cloughesy  TF, et al
    . Comparison between intensity normalization techniques for dynamic susceptibility contrast (DSC)-MRI estimates of cerebral blood volume (CBV) in human gliomas. J Magn Reson Imaging 2012;25:1472–77
  9. 9.↵


    1. 

    2. Boxerman  JL, 
    3. Schmainda  KM, 
    4. Weisskoff  RM
    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67
    Abstract/FREE Full Text
  10. 10.↵


    1. 

    2. Boxerman  JL, 
    3. Prah  DE, 
    4. Paulson  ES, et al
    . The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33:1081–87
    Abstract/FREE Full Text
  11. 11.↵


    1. 

    2. Henderson  E, 
    3. Sykes  J, 
    4. Drost  D, et al
    . Simultaneous MRI measurement of blood flow, blood volume, and capillary permeability in mammary tumors using two different contrast agents. J Magn Reson Imaging 2000;12:991–1003
    CrossRefPubMedWeb of Science
  12. 12.↵


    1. 

    2. Mills  SJ, 
    3. Patankar  TA, 
    4. Haroon  HA, et al
    . Do cerebral blood volume and contrast transfer coefficient predict prognosis in human glioma? AJNR Am J Neuroradiol 2006;27:853–58
    Abstract/FREE Full Text
  13. 13.↵


    1. 

    2. Venkatasubramanian  R, 
    3. Arenas  RB, 
    4. Henson  MA, et al
    . Mechanistic modelling of dynamic MRI data predicts that tumour heterogeneity decreases therapeutic response. Br J Cancer 2010;103:486–97
    CrossRefPubMed
  14. 14.↵


    1. 

    2. Tofts  PS
    . Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91–101
    CrossRefPubMedWeb of Science
  15. 15.↵


    1. 

    2. Nguyen  TB, 
    3. Cron  GO, 
    4. Mercier  JF, et al
    . Diagnostic accuracy of dynamic contrast-enhanced MR imaging using a phase-derived vascular input function in the preoperative grading of gliomas. AJNR Am J Neuroradiol 2012;33:1539–45
    Abstract/FREE Full Text
  16. 16.↵


    1. 

    2. Shankar  JJ, 
    3. Nguyen  TB, 
    4. Woulfe  J, et al
    . Evaluation of CT perfusion in grading and prognostication of high grade gliomas: a pilot study. AJR Am J Roentgenol 2013;200:W504–09
    CrossRefPubMed
  17. 17.↵


    1. 

    2. Awasthi  R, 
    3. Pandey  CM, 
    4. Sahoo  P, et al
    . Dynamic contrast-enhanced magnetic resonance imaging-derived kep as potential biomarker of matrix metalloproteinase 9 expression in patients with glioblastoma multiforme: a pilot study. J Comput Assist Tomogr 2012;36:125–30
    CrossRefPubMed
  18. 18.↵


    1. 

    2. Jain  R, 
    3. Poisson  L, 
    4. Narang  J, et al
    . Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. Radiology 2013;267:212–20
    CrossRefPubMed
  19. 19.↵


    1. 

    2. Takahashi  Y, 
    3. Nakamura  H, 
    4. Makino  K, et al
    . Prognostic value of isocitrate dehydrogenase 1, O6-methyguanine-DNA methyltransferase promoter methylation, and 1p19q co-deletion in Japanese malignant glioma patients. World J Surg Oncol 2013;11:284
    CrossRefPubMed
  20. 20.↵


    1. 

    2. Leach  MO, 
    3. Brindle  KM, 
    4. Evelhoch  JL, et al
    . The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92:1599–610
    CrossRefPubMedWeb of Science
  21. 21.↵


    1. 

    2. Song  HK, 
    3. Xue  Y, 
    4. Yu  J, et al
    . Comparison of the standard gadolinium concentration and signal difference methodologies for computation of perfusion parameters in DCE-MRI at various SNRs. In: Proceedings of the Annual Meeting of the International Society of Magnetic Resonance in Medicine, Montreal, Quebec, Canada. April 20–26, 2011
  22. 22.↵


    1. 

    2. Zaki  HS, 
    3. Jenkinson  MD, 
    4. Duplessis  DG, et al
    . Vanishing contrast enhancement in malignant glioma after corticosteroid treatment. Acta Neurochir (Wien) 2004;146:841–45
    PubMed
  23. 23.↵


    1. 

    2. Darpolor  M, 
    3. Molthen  RC, 
    4. Schmainda  KM
    . Multimodality imaging of abnormal vascular perfusion and morphology in preclinical 9L gliosarcoma model. PLoS One 2011;6:e16621
    CrossRefPubMed
  24. 24.↵


    1. 

    2. Badruddoja  MA, 
    3. Krouwer  HG, 
    4. Rand  SD, et al
    . Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. Neuro Oncol 2003;5:235–43
    Abstract/FREE Full Text
  25. 25.↵


    1. 

    2. Bastin  ME, 
    3. Carpenter  TK, 
    4. Armitage  PA, et al
    . Effects of dexamethasone on cerebral perfusion and water diffusion in patients with high-grade glioma. AJNR Am J Neuroradiol 2006;27:402–08
    Abstract/FREE Full Text
  


  
  



  




  


  
  



  
      
  
  

    
  


  
  



  
      
  
  

     Back to top  


  
  



			

		

		
		

			

			  

  
        
In this issue

    
  
  

    
  


  
  



  
      
  
  

    

  

    

  
      
  
  

    


Advertisement



  



  


  
  



  



  


  
  



  
      
  
  

    

	  
  

		

          

            

  
      
  
  

     Print  


  
  



  
      
  
  

     Download PDF  


  
  



  
      
  
  

    
 Email Article
  


  
  



  
      
  
  

    
 Citation Tools
  


  
  



          

        

        
        

          

            



  
      
  
  

    

  

    

  
      
  
  

    

  
  
  
  
      
Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI–Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas
  
    	
T.B. Nguyen, G.O. Cron, J.F. Mercier, C. Foottit, C.H. Torres, S. Chakraborty, J. Woulfe, G.H. Jansen, J.M. Caudrelier, J. Sinclair, M.J. Hogan, R.E. Thornhill, I.G. Cameron

  
    	
American Journal of Neuroradiology Jan 2015, 36 (1) 63-69; DOI: 10.3174/ajnr.A4006 

  
  
  



  


  
  



  
      
  
  

    

  
    
  
  
    
  
  
    
  


  


  
  



  
      
  
  

    
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  


  
  



  



  


  
  



  
      
  
  

    
  


  
  



          

        

	
 	
	
	


  


  
  



  
      
  
  

    
              Purchase  


  
  



  
        
Jump to section

    
  
  

    
  


  
  



  
      
  
  

    
  


  
  



			

		

	
	
 	
	
	


    

  



  

                
    

      

  

    

  
      
  
  

    


Advertisement